Using Platelet-rich Fibrin in Regenerative Endodontic Treatment in Mature Permanent Teeth

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Medicine and Pharmacy at Ho Chi Minh City

About this trial

This study aims to evaluate the antibacterial effects of injectable platelet-rich fibrin (i-PRF) in vitro, and to assess the clinical and radiographic outcomes of using advanced platelet-rich fibrin (A-PRF+) and i-PRF in regenerative endodontic treatment of mature permanent teeth with necrotic pulp. The study will compare the effectiveness of PRF-based treatment with conventional blood clot-based regenerative endodontics.

Eligibility criteria

Qualifiers

None

Disqualifiers

The tooth has had previous endodontic treatment.

The root apex is not fully developed, or there is root resorption/cracking/fracture.

The tooth has severe tooth loss and is indicated for extraction, or is indicated for restoration with a post or cast core after endodontic treatment.

The root canal is calcified.

Trial design

Treatments tested in this trial

  • Using advanced platelet-rich fibrin (A-PRF+) or injectable platelet-rich fibrin (i-PRF) in regenerative endodontic treatment in mature permanent teeth.

Treatment groups

No treatment groups listed

Sponsors and collaborators

University of Medicine and Pharmacy at Ho Chi Minh City

Lead sponsor

Odonto-Maxillo Facial Hospital in Ho Chi Minh City

Collaborator